Healthcare and Life Sciences
Turnover in health and human services has been on an upward trajectory for much of the last ten years, though the rate of growth has been subject to a slowdown of late. This has largely been driven by a combination of austerity measures, a slowing rate of increase of government spending on healthcare, and changing consumer habits, for instance, through lower levels of dental expenditure.
More widespread adoption of technology and intelligence looks set to fundamentally alter access to healthcare in the coming years, ranging from the use of virtual doctors to complex treatment processes. Such adoption presents considerable opportunity for health and digital businesses alike.
With British research institutions potentially being key to Covid-19 vaccine development efforts, a long-term boost to the wider healthcare industry could arise, encompassing businesses across the subfields of pharmaceuticals, life sciences, and social care.